What this means in practice for the optimization-focused research community: triple agonism appears to add a distinct energy expenditure component on top of the appetite suppression and enhanced insulin signaling already established by dual agonism
Growth hormone and secretagogues can have negative effects on insulin sensitivity, leading to increased A1C levels, and can also cause hunger and other side effects 4m10s
This test analyzes 14 metabolic pathways involving 49 peptides and 150+ genetic insights, including variants in GLP1R (rs6923761), GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313)
Deviating from this schedule was not tested in research, so safety and efficacy data do not support every-6-days dosing
So far, injectable obesity medications have proven to be highly efficacious and safe for use, but persistence on therapy remains challenging, Dr Aronne said
I think Surprise is probably the most important element for that reason: forces the brain to become active and decode what's happening